Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $471000.0.

  • Celularity's Share-based Compensation fell 8237.28% to $471000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 4954.52%. This contributed to the annual value of $11.6 million for FY2024, which is 2296.06% down from last year.
  • Latest data reveals that Celularity reported Share-based Compensation of $471000.0 as of Q3 2025, which was down 8237.28% from $108000.0 recorded in Q2 2025.
  • Celularity's Share-based Compensation's 5-year high stood at $28.2 million during Q2 2021, with a 5-year trough of $108000.0 in Q2 2025.
  • Its 5-year average for Share-based Compensation is $4.5 million, with a median of $3.0 million in 2024.
  • As far as peak fluctuations go, Celularity's Share-based Compensation skyrocketed by 14003.96% in 2022, and later tumbled by 9638.8% in 2025.
  • Quarter analysis of 5 years shows Celularity's Share-based Compensation stood at $1.9 million in 2021, then surged by 126.9% to $4.4 million in 2022, then dropped by 18.49% to $3.6 million in 2023, then dropped by 17.73% to $2.9 million in 2024, then crashed by 83.99% to $471000.0 in 2025.
  • Its Share-based Compensation stands at $471000.0 for Q3 2025, versus $108000.0 for Q2 2025 and $2.6 million for Q1 2025.